Dirk Thye - Net Worth and Insider Trading
Dirk Thye Net Worth
The estimated net worth of Dirk Thye is at least $852,380 dollars as of 2025-04-11. Dirk Thye is the CEO AND CHIEF MEDICAL OFFICER of Quince Therapeutics Inc and owns about 843,941 shares of Quince Therapeutics Inc (QNCX) stock worth over $852,380. Details can be seen in Dirk Thye's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Dirk Thye has not made any transactions after 2024-08-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Dirk Thye
Dirk Thye Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Dirk Thye owns 2 companies in total, including Cidara Therapeutics Inc (CDTX) , and Quince Therapeutics Inc (QNCX) .
Click here to see the complete history of Dirk Thye’s form 4 insider trades.
Insider Ownership Summary of Dirk Thye
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CDTX | Cidara Therapeutics Inc | 2015-04-14 | Chief Medical Officer |
| QNCX | Quince Therapeutics Inc | 2024-08-30 | director & Chief Executive Officer |
Dirk Thye Latest Holdings Summary
Dirk Thye currently owns a total of 1 stock. Dirk Thye owns 843,941 shares of Quince Therapeutics Inc (QNCX) as of August 30, 2024, with a value of $852,380.
Latest Holdings of Dirk Thye
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| QNCX | Quince Therapeutics Inc | 2024-08-30 | 843,941 | 1.01 | 852,380 |
Holding Weightings of Dirk Thye
Dirk Thye Form 4 Trading Tracker
According to the SEC Form 4 filings, Dirk Thye has made a total of 3 transactions in Quince Therapeutics Inc (QNCX) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Quince Therapeutics Inc is the acquisition of 154,500 shares on August 30, 2024, which cost Dirk Thye around $106,605.
Insider Trading History of Dirk Thye
- 1
Dirk Thye Trading Performance
GuruFocus tracks the stock performance after each of Dirk Thye's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Dirk Thye is 49.08%. GuruFocus also compares Dirk Thye's trading performance to market benchmark return within the same time period. The performance of stocks bought by Dirk Thye within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Dirk Thye's insider trading performs compared to the benchmark.
Performance of Dirk Thye
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 6.28 | | | | | |
| Relative Return to S&P 500(%) | 6 | | | | | |
Dirk Thye Ownership Network
Ownership Network List of Dirk Thye
Ownership Network Relation of Dirk Thye
Dirk Thye Owned Company Details
What does Cidara Therapeutics Inc do?
Who are the key executives at Cidara Therapeutics Inc?
Dirk Thye is the Chief Medical Officer of Cidara Therapeutics Inc. Other key executives at Cidara Therapeutics Inc include Chief Scientific Officer Leslie Tari , CHIEF LEGAL OFFICER Shane Ward , and Chief Medical Officer Taylor Sandison .
Cidara Therapeutics Inc (CDTX) Insider Trades Summary
Over the past 18 months, Dirk Thye made no insider transaction in Cidara Therapeutics Inc (CDTX). Other recent insider transactions involving Cidara Therapeutics Inc (CDTX) include a net sale of 23,711 shares made by Leslie Tari , a net sale of 22,137 shares made by Shane Ward , and a net sale of 21,586 shares made by Taylor Sandison .
In summary, during the past 3 months, insiders sold 3,437 shares of Cidara Therapeutics Inc (CDTX) in total and bought 0 shares, with a net sale of 3,437 shares. During the past 18 months, 9,325 shares of Cidara Therapeutics Inc (CDTX) were sold and 8,000 shares were bought by its insiders, resulting in a net sale of 1,325 shares.
Cidara Therapeutics Inc (CDTX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Cidara Therapeutics Inc Insider Transactions
Dirk Thye Mailing Address
Above is the net worth, insider trading, and ownership report for Dirk Thye. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Dirk Thye's mailing address is: San Diego Ca 92121.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
